Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Oncology Treatment Drug
1.2 Key Market Segments
1.2.1 Oncology Treatment Drug Segment by Type
1.2.2 Oncology Treatment Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Oncology Treatment Drug Market Overview
2.1 Global Market Overview
2.1.1 Global Oncology Treatment Drug Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Oncology Treatment Drug Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Oncology Treatment Drug Market Competitive Landscape
3.1 Global Oncology Treatment Drug Sales by Manufacturers (2019-2024)
3.2 Global Oncology Treatment Drug Revenue Market Share by Manufacturers (2019-2024)
3.3 Oncology Treatment Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Oncology Treatment Drug Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Oncology Treatment Drug Sales Sites, Area Served, Product Type
3.6 Oncology Treatment Drug Market Competitive Situation and Trends
3.6.1 Oncology Treatment Drug Market Concentration Rate
3.6.2 Global 5 and 10 Largest Oncology Treatment Drug Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Oncology Treatment Drug Industry Chain Analysis
4.1 Oncology Treatment Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Oncology Treatment Drug Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Oncology Treatment Drug Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Oncology Treatment Drug Sales Market Share by Type (2019-2024)
6.3 Global Oncology Treatment Drug Market Size Market Share by Type (2019-2024)
6.4 Global Oncology Treatment Drug Price by Type (2019-2024)
7 Oncology Treatment Drug Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Oncology Treatment Drug Market Sales by Application (2019-2024)
7.3 Global Oncology Treatment Drug Market Size (M USD) by Application (2019-2024)
7.4 Global Oncology Treatment Drug Sales Growth Rate by Application (2019-2024)
8 Oncology Treatment Drug Market Segmentation by Region
8.1 Global Oncology Treatment Drug Sales by Region
8.1.1 Global Oncology Treatment Drug Sales by Region
8.1.2 Global Oncology Treatment Drug Sales Market Share by Region
8.2 North America
8.2.1 North America Oncology Treatment Drug Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Oncology Treatment Drug Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Oncology Treatment Drug Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Oncology Treatment Drug Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Oncology Treatment Drug Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Roche
9.1.1 Roche Oncology Treatment Drug Basic Information
9.1.2 Roche Oncology Treatment Drug Product Overview
9.1.3 Roche Oncology Treatment Drug Product Market Performance
9.1.4 Roche Business Overview
9.1.5 Roche Oncology Treatment Drug SWOT Analysis
9.1.6 Roche Recent Developments
9.2 Celgene
9.2.1 Celgene Oncology Treatment Drug Basic Information
9.2.2 Celgene Oncology Treatment Drug Product Overview
9.2.3 Celgene Oncology Treatment Drug Product Market Performance
9.2.4 Celgene Business Overview
9.2.5 Celgene Oncology Treatment Drug SWOT Analysis
9.2.6 Celgene Recent Developments
9.3 Novartis
9.3.1 Novartis Oncology Treatment Drug Basic Information
9.3.2 Novartis Oncology Treatment Drug Product Overview
9.3.3 Novartis Oncology Treatment Drug Product Market Performance
9.3.4 Novartis Oncology Treatment Drug SWOT Analysis
9.3.5 Novartis Business Overview
9.3.6 Novartis Recent Developments
9.4 Bristol-Myers Squibb
9.4.1 Bristol-Myers Squibb Oncology Treatment Drug Basic Information
9.4.2 Bristol-Myers Squibb Oncology Treatment Drug Product Overview
9.4.3 Bristol-Myers Squibb Oncology Treatment Drug Product Market Performance
9.4.4 Bristol-Myers Squibb Business Overview
9.4.5 Bristol-Myers Squibb Recent Developments
9.5 Johnson and Johnson
9.5.1 Johnson and Johnson Oncology Treatment Drug Basic Information
9.5.2 Johnson and Johnson Oncology Treatment Drug Product Overview
9.5.3 Johnson and Johnson Oncology Treatment Drug Product Market Performance
9.5.4 Johnson and Johnson Business Overview
9.5.5 Johnson and Johnson Recent Developments
9.6 Merck and Co.
9.6.1 Merck and Co. Oncology Treatment Drug Basic Information
9.6.2 Merck and Co. Oncology Treatment Drug Product Overview
9.6.3 Merck and Co. Oncology Treatment Drug Product Market Performance
9.6.4 Merck and Co. Business Overview
9.6.5 Merck and Co. Recent Developments
9.7 AstraZeneca
9.7.1 AstraZeneca Oncology Treatment Drug Basic Information
9.7.2 AstraZeneca Oncology Treatment Drug Product Overview
9.7.3 AstraZeneca Oncology Treatment Drug Product Market Performance
9.7.4 AstraZeneca Business Overview
9.7.5 AstraZeneca Recent Developments
9.8 Pfizer
9.8.1 Pfizer Oncology Treatment Drug Basic Information
9.8.2 Pfizer Oncology Treatment Drug Product Overview
9.8.3 Pfizer Oncology Treatment Drug Product Market Performance
9.8.4 Pfizer Business Overview
9.8.5 Pfizer Recent Developments
9.9 Amgen
9.9.1 Amgen Oncology Treatment Drug Basic Information
9.9.2 Amgen Oncology Treatment Drug Product Overview
9.9.3 Amgen Oncology Treatment Drug Product Market Performance
9.9.4 Amgen Business Overview
9.9.5 Amgen Recent Developments
9.10 Eli Lilly
9.10.1 Eli Lilly Oncology Treatment Drug Basic Information
9.10.2 Eli Lilly Oncology Treatment Drug Product Overview
9.10.3 Eli Lilly Oncology Treatment Drug Product Market Performance
9.10.4 Eli Lilly Business Overview
9.10.5 Eli Lilly Recent Developments
9.11 AbbVie
9.11.1 AbbVie Oncology Treatment Drug Basic Information
9.11.2 AbbVie Oncology Treatment Drug Product Overview
9.11.3 AbbVie Oncology Treatment Drug Product Market Performance
9.11.4 AbbVie Business Overview
9.11.5 AbbVie Recent Developments
9.12 Takeda
9.12.1 Takeda Oncology Treatment Drug Basic Information
9.12.2 Takeda Oncology Treatment Drug Product Overview
9.12.3 Takeda Oncology Treatment Drug Product Market Performance
9.12.4 Takeda Business Overview
9.12.5 Takeda Recent Developments
9.13 Astellas
9.13.1 Astellas Oncology Treatment Drug Basic Information
9.13.2 Astellas Oncology Treatment Drug Product Overview
9.13.3 Astellas Oncology Treatment Drug Product Market Performance
9.13.4 Astellas Business Overview
9.13.5 Astellas Recent Developments
9.14 Ipsen
9.14.1 Ipsen Oncology Treatment Drug Basic Information
9.14.2 Ipsen Oncology Treatment Drug Product Overview
9.14.3 Ipsen Oncology Treatment Drug Product Market Performance
9.14.4 Ipsen Business Overview
9.14.5 Ipsen Recent Developments
9.15 Sanofi
9.15.1 Sanofi Oncology Treatment Drug Basic Information
9.15.2 Sanofi Oncology Treatment Drug Product Overview
9.15.3 Sanofi Oncology Treatment Drug Product Market Performance
9.15.4 Sanofi Business Overview
9.15.5 Sanofi Recent Developments
9.16 Bayer
9.16.1 Bayer Oncology Treatment Drug Basic Information
9.16.2 Bayer Oncology Treatment Drug Product Overview
9.16.3 Bayer Oncology Treatment Drug Product Market Performance
9.16.4 Bayer Business Overview
9.16.5 Bayer Recent Developments
9.17 Biogen Idec
9.17.1 Biogen Idec Oncology Treatment Drug Basic Information
9.17.2 Biogen Idec Oncology Treatment Drug Product Overview
9.17.3 Biogen Idec Oncology Treatment Drug Product Market Performance
9.17.4 Biogen Idec Business Overview
9.17.5 Biogen Idec Recent Developments
9.18 Teva
9.18.1 Teva Oncology Treatment Drug Basic Information
9.18.2 Teva Oncology Treatment Drug Product Overview
9.18.3 Teva Oncology Treatment Drug Product Market Performance
9.18.4 Teva Business Overview
9.18.5 Teva Recent Developments
9.19 Otsuka
9.19.1 Otsuka Oncology Treatment Drug Basic Information
9.19.2 Otsuka Oncology Treatment Drug Product Overview
9.19.3 Otsuka Oncology Treatment Drug Product Market Performance
9.19.4 Otsuka Business Overview
9.19.5 Otsuka Recent Developments
9.20 Eisai
9.20.1 Eisai Oncology Treatment Drug Basic Information
9.20.2 Eisai Oncology Treatment Drug Product Overview
9.20.3 Eisai Oncology Treatment Drug Product Market Performance
9.20.4 Eisai Business Overview
9.20.5 Eisai Recent Developments
9.21 Merck KGaA
9.21.1 Merck KGaA Oncology Treatment Drug Basic Information
9.21.2 Merck KGaA Oncology Treatment Drug Product Overview
9.21.3 Merck KGaA Oncology Treatment Drug Product Market Performance
9.21.4 Merck KGaA Business Overview
9.21.5 Merck KGaA Recent Developments
9.22 Gilead Sciences
9.22.1 Gilead Sciences Oncology Treatment Drug Basic Information
9.22.2 Gilead Sciences Oncology Treatment Drug Product Overview
9.22.3 Gilead Sciences Oncology Treatment Drug Product Market Performance
9.22.4 Gilead Sciences Business Overview
9.22.5 Gilead Sciences Recent Developments
10 Oncology Treatment Drug Market Forecast by Region
10.1 Global Oncology Treatment Drug Market Size Forecast
10.2 Global Oncology Treatment Drug Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Oncology Treatment Drug Market Size Forecast by Country
10.2.3 Asia Pacific Oncology Treatment Drug Market Size Forecast by Region
10.2.4 South America Oncology Treatment Drug Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Oncology Treatment Drug by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Oncology Treatment Drug Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Oncology Treatment Drug by Type (2025-2030)
11.1.2 Global Oncology Treatment Drug Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Oncology Treatment Drug by Type (2025-2030)
11.2 Global Oncology Treatment Drug Market Forecast by Application (2025-2030)
11.2.1 Global Oncology Treatment Drug Sales (Kilotons) Forecast by Application
11.2.2 Global Oncology Treatment Drug Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
